Keren Ladin1, Douglas W Hanto. 1. aDepartments of Occupational Therapy and Community Health, Research on Ethics, Aging, and Community Health (REACH Lab), Tufts University, Medford, Massachusetts bVanderbilt Transplant Center and Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Abstract
PURPOSE OF REVIEW: Geographic variation in liver transplantation has been the subject of extensive scrutiny, reflecting concerns that location is unfairly determinative for people needing organ transplantation. Drawing upon a number of established ethical approaches, we examine whether geographic differences in access to livers are inherently unethical. RECENT FINDINGS: We posit that the ethical imperative for redistribution largely hinges upon the belief that access to organs systematically disadvantages certain identifiable groups of patients over others. Yet, our data suggest that regions likely to be net-contributors may suffer from less access to transplantation and other health services, fewer social protections and greater burden of liver disease. Drawing upon a number of ethical approaches, including strict egalitarianism, utilitarianism, Maximin, Reciprocity, Sen's Impartial Spectator and a health equity framework, we demonstrate that the current proposal has significant weaknesses, and may not achieve its goals of improving equity and efficiency. SUMMARY: Formulating effective policies and programs to ameliorate health inequalities requires an understanding of the interrelated causes of mortality disparities and specific interventions to mitigate these causes. Although our analysis does not indicate how ethically distribute livers, but it suggests that this be done with consideration for population-based health measures.
PURPOSE OF REVIEW: Geographic variation in liver transplantation has been the subject of extensive scrutiny, reflecting concerns that location is unfairly determinative for people needing organ transplantation. Drawing upon a number of established ethical approaches, we examine whether geographic differences in access to livers are inherently unethical. RECENT FINDINGS: We posit that the ethical imperative for redistribution largely hinges upon the belief that access to organs systematically disadvantages certain identifiable groups of patients over others. Yet, our data suggest that regions likely to be net-contributors may suffer from less access to transplantation and other health services, fewer social protections and greater burden of liver disease. Drawing upon a number of ethical approaches, including strict egalitarianism, utilitarianism, Maximin, Reciprocity, Sen's Impartial Spectator and a health equity framework, we demonstrate that the current proposal has significant weaknesses, and may not achieve its goals of improving equity and efficiency. SUMMARY: Formulating effective policies and programs to ameliorate health inequalities requires an understanding of the interrelated causes of mortality disparities and specific interventions to mitigate these causes. Although our analysis does not indicate how ethically distribute livers, but it suggests that this be done with consideration for population-based health measures.
Authors: D F Kappel; W C Chapman; S Conrad; A Reed; R Linderer; S Dunn; P Niles; M F Levy; T Cawiezell Journal: Am J Transplant Date: 2015-06-10 Impact factor: 8.086
Authors: Alan Reed; William C Chapman; Stuart Knechtle; Kenneth Chavin; Richard Gilroy; Goran B G Klintmalm Journal: Ann Surg Date: 2015-08 Impact factor: 12.969
Authors: Abbas Rana; Bruce Kaplan; Irbaz B Riaz; Marian Porubsky; Shahid Habib; Horacio Rilo; Angelika C Gruessner; Rainer W G Gruessner Journal: Transplantation Date: 2015-03 Impact factor: 4.939
Authors: Macarena C García; Brigham Bastian; Lauren M Rossen; Robert Anderson; Arialdi Miniño; Paula W Yoon; Mark Faul; Greta Massetti; Cheryll C Thomas; Yuling Hong; Michael F Iademarco Journal: MMWR Morb Mortal Wkly Rep Date: 2016-11-18 Impact factor: 17.586
Authors: A B Massie; B Caffo; S E Gentry; E C Hall; D A Axelrod; K L Lentine; M A Schnitzler; A Gheorghian; P R Salvalaggio; D L Segev Journal: Am J Transplant Date: 2011-09-15 Impact factor: 8.086
Authors: D A DuBay; P A MacLennan; R D Reed; M Fouad; M Martin; C B Meeks; G Taylor; M L Kilgore; M Tankersley; S H Gray; J A White; D E Eckhoff; J E Locke Journal: Am J Transplant Date: 2015-02 Impact factor: 8.086
Authors: S E Gentry; E K H Chow; N Dzebisashvili; M A Schnitzler; K L Lentine; C E Wickliffe; E Shteyn; J Pyke; A Israni; B Kasiske; D L Segev; D A Axelrod Journal: Am J Transplant Date: 2016-01-18 Impact factor: 8.086